Aims: In this study, we aim to determine the impact that compliance with weight loss protocols can have on weight management for patients after initial staging of metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease (MASLD). Methods: We retrospectively evaluated medical records for patients seen between 2020 and 2022 for a FibroScan exam, application of a weight loss protocol, and recording of their weight change from the date of their first appointment through August 2023. Results: We analyzed the data for a cohort of 871 patients who were 65% female and whose mean age was 50.91 years. These 871 patients were all seen by La Maestra Community Health Center's Liver Clinic for a Fibroscan and were advised weight loss. Five hundred sixty of these patients complied with at least 1 weight loss protocol step (signing weight loss contract, receiving health education, meeting with a dietician and/or following up regarding weight loss) and lost significantly more weight than the 311 patients who did not (-3.39 lbs v -0.90 lbs; P < 0.01, 95% Cl, 1.11-1.97). Conclusion: Taken together, our data demonstrate that patients who are more compliant with weight management protocols are shown to have substantially more weight loss.
There are countless dieticians, nutritionists, and health gurus out there, some of whom are certified and some who are not, with differing views in regards to what a perfect diet looks like; however, there is no one who denies that throughout the course of human existence, animal foods have been hunted and incorporated as an integral part of the evolution and continuation of our species.
Background: Secondary Male Hypogonadism (SMH), described as dysfunction of the hypothalamic-pituitarytesticular axis, is commonly caused by obesity. Objectives:To evaluate the effect of decreasing body weight and waist circumference (WC) on male sex hormones in obese men. Methods:Retrospective study; reviewed the medical records: 42 male patients; ABC region, São Paulo state; aged between 28 and 69 years.Evaluated: body weight, height, WC, total cholesterol (TC) and fractions, liver enzymes, alkaline phosphatase (AP), total testosterone (TT), free testosterone (FT), sex hormone-binding globulin (SHBG), estradiol (E2), luteinizing hormone (LH), folliclestimulating hormone (FSH), Body Mass Index (BMI); men previously diagnosed with obesity (BMI ≥ 30 kg/m 2 ).A descriptive data analysis was performed.Quantitative variables were presented as measures of central tendency and variability according to the data distribution using the Shapiro-Wilk test.To compare the clinical variables before and after treatment, the paired t-test and Wilcoxon test were used to analyze the normality of the data.Results: After the decrease in body weight: significant decrease in aspartate transaminase (SGOT/AST), pyruvic transaminase (SGPT/ALT), gamma glutamyl transferase (γGT), SHBG, weight, BMI, waist circumference (WC), TC, low-density lipoprotein (LDL) cholesterol, very low density lipoproteins (VLDL) cholesterol and E2 values.Highdensity lipoprotein (HDL) cholesterol, TT, and FT levels were significantly higher after the decrease in body weight.Conclusions: In men with obesity, SMH, and increased WC, the most recommended treatment is a reduction in body weight and patients are counseled to avoid the use of exogenous testosterone, which can lead to testicular atrophy and late infertility.
Background: Obesity is described as deviation from normal fat accumulation which endangers the health of an individual. The Body Mass Index (BMI) is normally used to indicate whether an individual is obese or otherwise. Different options of treatments are used in obesity reduction. Nurses play a significant role in providing medical care in obesity reduction. Objectives: The study aimed at exploring the perceptions nurses have on obesity treatment options at the Korle-Bu Teaching Hospital, in the Greater Accra Region of Ghana. Methods: The study used is an exploratory, descriptive qualitative design. Twelve (12) participants (nurses) were purposively sampled for the study. A semi-structured interview was also used to collect data from the participants. All the interviews were audio recorded, transcribed verbatim and analyzed using thematic content analysis, coding and categorization. Findings: Findings show that 7 (58.3%) of the participants hold the view that obesity treatment options help to reduce weight and prolong the lifespan of patients. Conversely, 4 (33.3%) of participants argue that treatment options such as exercise, surgery, diet and herbal preparations might be costly or cheap. Conclusions: Based on the findings, the need for food and exercise policies in all hospital settings was recommended. The need for workshops and specialists’ courses to train nurses on obesity treatments was also emphasized.
Obesity has become a worldwide epidemic disease. It is a complex disease involving an excessive amount of body fat. Obesity isn't just a cosmetic concern. It's a medical problem that increases the risk of other diseases and health problems, such as heart disease, diabetes, high blood pressure and certain cancer. Besides, it has been pointed out as a vital cause of kidney diseases. Due to its close association with diabetes and hypertension, excess weight and obesity are important risk factors for chronic kidney disease (CKD).
This was a school–based cross-sectional study. Consenting secondary school adolescents aged 10 to 18 years in Owo Local Government Area completed a pretested semi structured questionnaire. Anthropometric parameters were measured using standard methods. Overweight and Obesity were defined using Centre for Disease Control Body Mass Index percentile cut-off. Data were analysed using descriptive and inferential statistics.
The article aims to compare phentermine and liraglutide for weight loss management in the primary care setting. The article will examine current research regarding these two medications in order to provide relevant information pertaining to prescribing and providing education to patients interested in these medications. *Corresponding author: Rachel Johnson, Carson-Newman University, 6908 Holly Ct, Matthews, NC 28104, USA, Tel: 704299-1045 most effectively. There are times where people make those dietary and lifestyle changes and still cannot lose weight. Golden [3] asserts, “Obesity pharmacotherapy should be considered if intensive lifestyle interventions cannot meet or maintain weight-loss goals in those with a BMI of greater or equal to 30, or those with a BMI greater than or equal to 27 who have at least one obesity-related comorbidity” (p.544).
Obesity becomes the major public health problem worldwide and unhealthy lifestyles are the most risk factors of it. People wrongly perceive central obesity as an indicator of wealth group in western Ethiopian; however it is a midfielder for cardio-metabolism disorders. Thus, study aimed to assess the prevalence of overweight, obesity and associated factors among middle aged urban residents of west Ethiopia.
The prevalence of overweight and obesity had considerably increased in developing countries including Ethiopia. In Ethiopia, there is a large variation in prevalence across different regions. There is also inconsistency in the relationship of socioeconomic status (SES) and overweight/obesity across regions. These inconsistencies could make policymakers difficult to make a decision and designing appropriate intervention strategies.
Research shows that the United States adult obesity rate is at the highest national rates ever recorded. These numbers have substantially increased since 2008. Obesity-related health conditions include heart disease, stroke, diabetes and certain types of cancer. This disease is preventable, and can be reversed if providers take action now. Research shows that obesity can be managed with diet, exercise and sometimes medications, but education needs to start at the primary care level.
Background: Obesity in children has adverse effects on both health and psychology. Obesity is known to be influenced by environmental factors and genetic factors, as well as the interaction between genes and environment. Hai Phong city located in the northern part of Vietnam has rapid economic growth and urbanization. Along with the development, the percentage of obese children has increased. To date, there have been no studies on the relationship between risky factors and obesity in children in this city. The present study aimed to explore the association of eating behavior and parental BMI with obesity of Hai Phong primary school children. Methods: Anthropometric indices (height, weight and BMI) of total 4014 children from 6 to 10 years of age in 19 primary schools in Hai Phong city were measured. Obese children and normal weight children were classified using the criteria of BMI cut-off points proposed by the International Obesity Task Force. Then, 175 normal weight children and 169 obese children were studied to evaluate the association of eating behaviors and their parental BMI with obesity. Results: Eating behaviors that increased the risk of obesity included: Gluttonous characteristic (OR = 14.2), no extra-meal (OR = 2.9), no desired eating (OR = 2.3) and preference for fatty foods (OR = 3.3).The BMI of father and/or mother ≥ 23 kg/m2 significantly increased the risk of obesity in primary school children (OR = 2.9 and OR = 5.5). Conclusions: There was high association of eating behaviors and parental BMI with obesity of primary school children in Hai Phong city. Eating behaviors that increased the risk of obesity included gluttonous characteristic, no extra-meal, no desired eating and preference of fatty foods. High father and/or mother BMI also increased the risk of obesity in children.
Introduction: Obesity is defined as a multifactorial metabolic syndrome, in which there’s an excessive number of fat cells within the tissues. It’s discussed that intestinal microbiota might have a relevant relation with obesity, since it’s relevantly altered in obese patients. Objectives: To assess the effect of stool transplantation (ST) in the condition of obesity and its outcomes in an experimental model of cafeteria diet by hepatic function test, lipid profile, total glycemia and histology. Methods: 40 male wistar assigned in 5 groups: Control (CO), control with antibiotics (CO + ATB), obesity (CAF + ATB), stool transplantation (ATB + ST) and obesity with stool transplantation (CAF + ATB + ST). During the experiment, obesity induction groups received Cafeteria diet (CAF), whereas the remaining groups had normal diet ad libitum. After 3 months, daily ST was carried out for 8 weeks by gavage procedure. Animals were euthanized and mesenterial fat, aorta and liver were havested for further analysis. Results: It was observed that the CAF diet groups had a higher mesenterial fat weight compared to CO groups (p = 0.0078). Hepatic enzymes and free cholesterol also presented statistical significance comparing CO and CAF (p < 0.0001). There were no differences in laboratory tests between the groups that received ST and those that didn’t. The histopathological evaluation comparing CAF + ATB and CAF + ATB + ST showed that all groups presented steatosis and aortic lesion, but the ST groups had less signs of injure. Conclusion: CAF resulted in an expected obese metabolic syndrome. In relation to the ST, there were no beneficial results regarding glycemia and triglycerides.
Data collection includes people of full age who underwent Sleeve Gastrectomy or Gastric Bypass surgery between 2005 and 2017. The bougie is limited to 33-40 French for Sleeve Gastrectomy. Furthermore, the Roux-en-Y length for RYGB is set to 120-180 cm and the biliodigestive length is set to 40-60 cm.
Addressing obesity is now a crucial public health challenge due to its sharply rising prevalence and despite the considerable effort directed at this, success is not yet fully achieved. Evidence has shown that effectively changing human behaviour and lifestyle is a corporate approach for weight management with recognised worthy success in achieving weight loss and maintenance. Behavioural change techniques are now chief contributory factors to any weight management program.
Background: To assess outcomes of laparoscopic sleeve gastrectomy (LSG) as primary surgery (PS) versus revisional surgery (RS) emphasizing weight loss, modification of comorbidities and complications. Methods:The study included randomly selected 350 PS patients for control group and 35 RS patients for study group.Prospectively-collected patient data were retrospectively reviewed.To measure the efficacy of the procedure, we calculated the excess weight loss percentage (EWL%).Effective weight loss was accepted as more than 50%.The changes in the status of the comorbid diseases, complications (leakage, bleeding and stenosis), weight loss, % excessive weight loss (EWL) and mortality were recorded.Results: Mean BMI before PS and RS were 47.59 ± 6.46 kg/m 2 and 44.52 ± 6.75 kg/m 2 (p = 0.07).The mean operation time was more in the RS group than in the PS group.The amount of weight given in the RS group was higher one year after surgery.Diabetes mellitus (DM) and Dyslipidemia (DL) remission rates were higher in revision surgery group.There was one mortality in RS group. Conclusions:To summarize the first to systematically discuss results of primary surgery versus revisional surgery from Turkey and we showed the evidence that revisional surgery can be successfully completed with acceptable postoperative morbidity risks comparing with primary surgery.There is a need for long-term follow-up outcomes of large randomized controlled studies to define the related to weight loss and delayed complications.
A cross-sectional study was carried out in a government school in Buraydah, during academic year 2018-2019. All the study population were subjected to a predesigned questionnaire that included questions related to socio-demographic characteristics, life style (physical activity and eating habits) and anthropometric measurements including height, weight and body mass index.
A 31-year-old woman who carried a laparoscopic adjustable gastric banding for morbid obesity presented chronic postprandial vomiting and lack of efficacy with weight recovery three years after surgery. The adjustable gastric band was removed but symptoms did not improve. Morphologic and functional tests demonstrated a functional obstruction 5 to 6 cm below the oeso-gastric junction, probably related to a fibrous scare, which could explain symptoms.
